Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study

Transplant Proc. 1993 Feb;25(1 Pt 2):1431-3.

Authors

C Legendre¹, D Ducloux, A Ferroni, N Chkoff, C Valette, C Geffrier, C Rouzioux, H Kreis

Affiliation

¹ Transplantation Service, Necker Hospital, Paris, France.

PMID: 8382871

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Acyclovir / therapeutic use*
Adult
Case-Control Studies
Creatinine / blood
Cytomegalovirus Infections / epidemiology
Cytomegalovirus Infections / prevention & control*
Female
Graft Rejection / immunology
Graft Rejection / pathology
Graft Rejection / therapy
Humans
Immunosuppressive Agents / therapeutic use
Incidence
Kidney Transplantation* / immunology
Kidney Transplantation* / physiology
Male
Muromonab-CD3 / therapeutic use
Tissue Donors

Substances

Immunosuppressive Agents
Muromonab-CD3
Creatinine
Acyclovir